Clinical Trial Update: Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of fulranumab monotherapy for osteoarthritis of the hip or knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Fulranumab (fulranumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Osteoarthritis, Pain | Phase 3 | Status: COMPLETED